Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Goldstein

Showing results (131-140 of 194) with videos related to

Pageof 20
Sort By:
Urology|September 3, 2008
Re: Khurana et al.: Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans (Urology 2008;71:118-122)Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Medical Hypotheses|August 3, 2010
Altitude, body iron stores, and cancerLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Transplant Immunology|July 2, 2010
Why statin therapy may increase the risk for posttransplantation squamous cell carcinomaLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Neurology|April 28, 2010
Family history of melanoma and Parkinson disease riskLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Archives of Internal Medicine|June 24, 2009
Regarding the inverse relationship between blood pressure and outdoor temperature: it is the sunMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Cellular and Molecular Life Sciences : CMLS|July 3, 2009
Iron, type 2 diabetes mellitus, and Alzheimer's diseaseLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Clinical Endocrinology|January 28, 2009
Statin therapy as the fundamental therapy for cardiovascular prevention: be carefulLuca Mascitelli, Mark R Goldstein, Francesca Pezzetta
European Journal of Internal Medicine|November 18, 2008
Questioning the safety of statin therapy in the secondary prevention of strokeLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
International Journal of Cardiology|May 20, 2008
The double-edged sword of statin immunomodulationMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Lancet (London, England)|April 9, 2008
Cholesterol, statins, and mortalityMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Pageof 20

Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Urology|September 3, 2008
Re: Khurana et al.: Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans (Urology 2008;71:118-122)Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Medical Hypotheses|August 3, 2010
Altitude, body iron stores, and cancerLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Transplant Immunology|July 2, 2010
Why statin therapy may increase the risk for posttransplantation squamous cell carcinomaLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Neurology|April 28, 2010
Family history of melanoma and Parkinson disease riskLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Archives of Internal Medicine|June 24, 2009
Regarding the inverse relationship between blood pressure and outdoor temperature: it is the sunMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Cellular and Molecular Life Sciences : CMLS|July 3, 2009
Iron, type 2 diabetes mellitus, and Alzheimer's diseaseLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Clinical Endocrinology|January 28, 2009
Statin therapy as the fundamental therapy for cardiovascular prevention: be carefulLuca Mascitelli, Mark R Goldstein, Francesca Pezzetta
European Journal of Internal Medicine|November 18, 2008
Questioning the safety of statin therapy in the secondary prevention of strokeLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
International Journal of Cardiology|May 20, 2008
The double-edged sword of statin immunomodulationMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Lancet (London, England)|April 9, 2008
Cholesterol, statins, and mortalityMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Pageof 20